456 results on '"Langen KJ"'
Search Results
2. 18F-FET-PET imaging results in the spotlight of the WHO 2016 classification system
3. 18F-FET PET imaging following immunotherapy with DC vaccination in glioblastoma patients
4. Diagnosis of pseudoprogression following lomustine-temozolomide chemoradiation in newly diagnosed glioblastoma patients using FET PET
5. Excitatory-Inhibitory Balance within EEG Microstates and Resting-state fMRI Networks: Assessed via Simultaneous PET-MR-EEG Imaging
6. In-vivo Tierversuchsersatzmodell zur präklinischen Tumordiagnostik: PET-MR im Hühnerembryo
7. Imaging findings following regorafenib in malignant gliomas: FET PET adds valuable information to anatomical MRI
8. FET PET radiomics for the diagnosis of pseudoprogression in patients with glioblastoma
9. Improving the Diagnosis of Breast Cancer using a dedicated PET/MRI – The EU Project HYPMED
10. Einfluss des regionalen Blutvolumens auf die Zeitaktivitätskurve der FET-Anreicherung von Hirntumoren
11. The T2-FLAIR mismatch sign in IDH-mutant astrocytomas - Is there an association with FET PET uptake?
12. Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[ 18 F]-fluoroethyl)-L-tyrosine PET
13. Complete resection of biological tumor volume in 18F-FET-PET correlates with better overall survival in WHO grade III and grade IV glioma
14. Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumor-treating fields: Initial experiences
15. Evaluation of a Fit Model for Time Activity Curves of Dynamic FET PET Acquisitions
16. Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis
17. Differentiation of treatment-related changes from high-grade glioma progression: A direct comparison between FET PET and ADC values obtained by DWI MRI
18. FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma
19. Cerebral FET uptake owing to epilepsy appears to be a rare phenomenon
20. Comparison of [18F]-Fluoroethyltyrosine PET and the IDH status with Sodium MRI in Cerebral Gliomas
21. Impact of additional 18F-FET-PET imaging following immunotherapy with DC vaccination in GBM patients
22. Assessment of pseudoprogression in primary and secondary GBM using FET PET and molecular genetics
23. Pseudoprogression after dendritic cell vaccination and radiochemotherapy of a GBM patient
24. FET PET after tumour resection: Experimental study in a rat glioma model
25. The use of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma
26. Differentiation of local recurrent brain metastasis from radiation-induced changes using [18F]Fluoroethyl-L-Tyrosine PET
27. Detecting pseudoprogression in malignant glioma using CT-perfusion and FET-PET imaging – a non-randomized prospective single-center study
28. Multimodale bildgebende Diagnostik von Hirntumoren – FET-PET, fMRT und kortikale Stimulation für eine maßgeschneiderte Therapie
29. Präoperative multimodale Bildgebung bei Patienten mit hirneigenen Tumoren
30. Predictive value of 18F-FET PET in 169 newly diagnosed glioma suspective cerebral lesions
31. O-(2-18F-fluoroethyl)-L-tyrosine (FET) uptake kinetic with parametric mapping is superior in predicting tumor grade in gliomas
32. Comparison of FET-PET and 5-ALA fluorescence in gliomas
33. Comparison of FET PET and FDG PET in brain tumors
34. Stereotaktische Koregistrierung von Sprachaktivierung und Fluorethyl-L-Tyrosin-PET-Aktivierung bei Patienten mit linkshemisphärischen Hirntumoren
35. Unterscheidung neoplastischer von nicht neoplastischen Läsionen mit Ringenhancement durch ein Aminosäure-PET mit [18F]-fluoroethyl-l-tyrosine (FET)
36. Prospektive Untersuchung bildgebender und metabolischer Merkmale bei 11 Patienten mit neu diagnostizierten WHO Grad II oder III Gliomen: Gadolinium Anreicherung, FET-Aufnahme im PET und ALA induzierte Porphyrin-Fluoreszenz
37. Prognostischer Wert des Aminosäure-PET mit FET bei 40 Patienten mit neu diagnostizierten, niedriggradigen Gliomen
38. Prognostischer Wert des Aminosäure-PET mit FET bei 85 Patienten mit neu diagnostizierten, gliomverdächtigen intrazerebralen Läsionen
39. 68Ga-DOTATATE-PET imaging in spinal meningeoma - Case report
40. Diagnostic potential of O-(2-[F-18]Fluorethyl)-L-tyrosin-PET imaging in meningioma
41. Focal hypermetabolism in 18F-FDG PET indicates neuroinflammation and potential of postsurgical recovery in cervical myelopathy
42. Navigated TMS is more robust than monopolar direct cortical stimulation in patients with high resting motor threshold and tumors adjacent to the primary motor representation
43. The extent of perifocal edema in navigated TMS tracked motor fibers correlates to the primary motor deficit in patients with M1-adjacent intracerebral tumors
44. Comparative evaluation of CT perfusion versus FET-PET in differentiating recurrent malignant glioma from pseudoprogression
45. Prognostic value of 18F-FET PET, MRI and cytoreduction in 61 low-grade glioma
46. Patterns of normal and locally impaired glucose utilisation in degenerative monosegmental compressive myelopathy with predictive value for clinical recovery using 18F-FDG PET
47. Differentiating high vs. low grade gliomas using FET-PET in the presurgical assessment
48. Funktionelle Kartierung der primär-motorischen Repräsentation von Zunge, Hand und Fuß bei Patienten mit eloquent gelegenen, intracerebralen Tumoren – Vergleich von fMRT, nTMS und direkter Cortexstimulation
49. Stereotactic coregistration of cortical language areas and Fluorethyl-L-Tyrosin-PET activation in patients with left hemispheric gliomas
50. Differentiation of tumorous and non-tumorous intracerebral ring-enhancing lesions with positron emission tomography (PET) using the amino acid [18F]-fluoroethyl-l-tyrosine (FET)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.